Open AccessOptimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond
Author(s) -
Mazen M. Dimachkie
Publication year - 2022
Publication title -
rrnmf neuromuscular journal
Language(s) - English
Resource type - Journals
ISSN - 2692-3092
DOI - 10.17161/rrnmf.v3i2.16304
Subject(s) - medicine , chronic inflammatory demyelinating polyneuropathy , tolerability , adverse effect , placebo , clinical trial , weakness , antibody , surgery , immunology , pathology , alternative medicine